ADHD Medication FAQs
What should you know about ADHD medication in the UK? ADHD medicines can help manage symptoms for some people, but treatment choice and response vary between individuals, and between adults and children. Options include stimulant and non-stimulant medicines, both requiring ongoing monitoring and side-effect review. NHS guidance notes that adults may need to try more than one medicine to find what works, while NICE (National Institute for Health and Care Excellence) sets out specific recommendations for medication choice. These ADHD medication FAQs answer the questions people ask most.
ADHD Medication: Key Takeaways
- There is no single ADHD medicine that works best for everyone.
- Adults and children may have different treatment pathways.
- Stimulant and non-stimulant medicines work differently.
- Side effects and effectiveness should be monitored over time.
- Medication changes should always be discussed with an appropriate healthcare professional.
Understanding how ADHD medication works can help you have more informed conversations with your prescriber, but this guide is educational and does not replace individual medical advice. For adults managing an ongoing prescription, Pharmazon HomeCare’s ADHD pharmacy and prescription support services can help with the practical side of treatment.
Related ADHD Medication Guides
These FAQs answer some of the most common questions about ADHD medicines. For a complete overview of ADHD medication UK, including medication types, how medicines work and treatment options, visit our main ADHD medication guide.
You may also find these resources useful:
- How Does ADHD Medication Work? – Learn how different ADHD medicines work.
- Stimulant vs Non-Stimulant ADHD Medication – Compare the main types of ADHD medication.
- Can You Change ADHD Medication? – Understand what may happen when medication needs to be reviewed.
Weight-Loss Medication Specialist
GLP-1 Dispensing Expertise
Verify GPhC Registration
Reviewed by Archna Gudka, a GPhC-registered pharmacist with over two decades of experience in pharmacy, including 18 years in community pharmacy providing front-line patient care. At Pharmazon HomeCare, an ADHD specialist pharmacy, she has spent the past three years developing her clinical expertise in the management of ADHD and other neurodevelopmental conditions, supported by additional specialist training from the UK Adult ADHD Network (UKAAN). Her areas of clinical focus include ADHD care, neurodevelopmental support, weight management, and evidence-based, patient-centred pharmacy practice. This content is provided for general information only and should not replace personalised advice from your prescribing clinician or pharmacist. Next review: December 2026.
Frequency Asked Question
There is no single medication that is best for every adult. NICE guidance indicates lisdexamfetamine or methylphenidate as first-line pharmacological options, but the right choice depends on individual response, side effects and clinical assessment by a qualified prescriber.
Medication choice for children differs from adults. NICE guidance identifies methylphenidate as a commonly recommended first-line option for children aged five and over, though decisions are made individually by a paediatric specialist based on the child’s circumstances.
Concerta is a brand name for methylphenidate. Concerta XL is a modified-release formulation, meaning it releases the medicine gradually over the day rather than all at once, which can support more consistent symptom management with fewer daily doses.
Stimulants, such as methylphenidate and lisdexamfetamine, and non-stimulants, such as atomoxetine, work through different mechanisms. Stimulant medicines generally have a faster onset of effect than non-stimulants, though individual experience and suitability vary considerably.
Immediate-release formulations act quickly but need multiple daily doses, while modified or extended-release formulations release medicine gradually for longer coverage. NICE guidance suggests modified-release can support convenience and adherence, while immediate-release suits flexible dosing needs.
Onset varies by medicine and formulation rather than one universal timeframe. Some stimulants may act relatively quickly, while some non-stimulants take longer to show their full effect. A prescriber can advise on what to expect.
Duration depends on the specific medicine, formulation and individual response. This is distinct from how long a medicine remains detectable in the body, which can outlast its noticeable symptom-control effect. Your prescriber can clarify expected duration.
ADHD medicines influence brain signalling, particularly involving dopamine and noradrenaline, chemicals linked to attention and impulse control. Different medicines act on these systems in different ways, which is part of why they can feel different in practice.
Timing depends on the specific medicine and formulation prescribed. Rather than following a generic schedule, follow your prescriber’s instructions and the medicine information provided with your prescription, and raise timing questions during a review.
Yes, medication can sometimes be changed following clinical review. NICE guidance covers switching between medicines when adults do not get enough benefit from an adequate trial, including for reasons such as side effects or duration.
A perceived loss of effect can relate to changing circumstances, medication duration, adherence, side effects, individual response or possible tolerance. This calls for clinical review rather than self-adjustment, since several different explanations are possible.
Side effects vary by medicine and individual. Common considerations include appetite changes, sleep difficulties, headaches, nausea, and changes in heart rate or blood pressure. Persistent or concerning side effects should always be discussed with a healthcare professional.
Advice depends on the specific medicine, so there is no single generic instruction. Check the patient information leaflet for your medicine, or speak to your pharmacist or prescriber, rather than assuming standard advice applies.
Some ADHD medicines are prescribed for regular daily use, but treatment schedules vary between individuals and medicines. Always follow your specific prescription and clinician’s instructions rather than assuming a general daily-use pattern applies to you.
Dosage is individual and depends on the medicine, age, response, side effects and clinical circumstances. NICE guidance recommends treatment be tailored to individual needs. Only your prescriber can determine and adjust the correct dose for you.
Some people may experience anxiety or restlessness with certain ADHD medicines, though this does not happen universally. If anxiety becomes troublesome or persistent, this should be raised with the prescribing clinician as part of a treatment review.
Sleep changes can occur with some ADHD medicines, and timing, formulation and individual response can all play a part. NICE guidance recommends monitoring sleep patterns during treatment, so any disruption is worth raising with your prescriber.
Interactions depend on the specific ADHD medicine and whatever else is being taken. Always tell your prescriber or pharmacist about all medicines, supplements and relevant health conditions, since a complete interaction check needs individual clinical assessment.
Clinicians typically assess symptom control, side effects, adherence, sleep, duration of effect, daily functioning, and where appropriate blood pressure and heart rate. NICE guidance recommends regular review and monitoring throughout ADHD treatment.
Contact your pharmacy first to check availability, then speak to your prescriber if the medicine cannot be supplied so they can discuss clinically appropriate alternatives. Avoid unregulated sources, and see our guide on ADHD medication shortages and delivery options.
Signs include improved concentration, better task completion, reduced impulsivity, improved organisation and better daily functioning. Effectiveness should be judged by meaningful symptom and functional improvement, not simply by feeling a noticeable medication effect.
Sources
- GOV.UK (DHSC). Medicine supply management. Last updated 5 August 2026. https://www.gov.uk/guidance/medicine-supply-management
- GOV.UK (DHSC). Medicines that cannot be parallel exported from the UK. List dated 29 September 2026. https://www.gov.uk/government/publications/medicines-that-cannot-be-parallel-exported-from-the-uk
- GOV.UK (DHSC and NHS England). Managing a robust and resilient supply of medicines. Published 15 August 2025. https://www.gov.uk/government/publications/managing-a-robust-and-resilient-supply-of-medicines
- NHS Specialist Pharmacy Service. Prescribing and switching between modified-release methylphenidate. https://www.sps.nhs.uk/articles/prescribing-and-switching-between-modified-release-methylphenidate/
- Electronic Medicines Compendium. Elvanse 30mg Hard Capsules, Summary of Product Characteristics and Patient Information Leaflet. Takeda UK Ltd. https://www.medicines.org.uk/emc/product/14089/smpc
Last reviewed: [026-10-09]